Related Experiment Video
Updated: Jun 24, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Invasive pneumococcal disease surveillance in Canada, 2021-2022.
Averil Griffith1, Alyssa R Golden1, Brigitte Lefebvre2
1National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.
Invasive pneumococcal disease (IPD) cases decreased in 2021 but rose in 2022. Increasing serotypes and multidrug resistance highlight the need for ongoing surveillance of IPD in Canada.
Area of Science:
- Microbiology
- Epidemiology
- Public Health
Background:
- Invasive pneumococcal disease (IPD) is a nationally notifiable disease in Canada.
- Conjugate vaccine use has altered the distribution of Streptococcus pneumoniae serotypes over time.
- This report summarizes IPD demographics, serotypes, and antimicrobial resistance in Canada for 2021-2022.
Purpose of the Study:
- To summarize the demographics, serotypes, and antimicrobial resistance patterns of IPD isolates in Canada.
- To analyze trends in IPD incidence and serotype distribution.
- To assess the prevalence of antimicrobial resistance in IPD isolates.
Main Methods:
- National surveillance of IPD isolates conducted by the National Microbiology Laboratory (NML) and collaborating laboratories.
- Serotyping performed using Quellung reaction or whole-genome sequencing (WGS).
- Antimicrobial susceptibility determined by WGS, broth microdilution, or shared data; incidence rates from Canadian Notifiable Disease Surveillance System.
Main Results:
- IPD incidence was 5.62 cases/100,000 population in 2021, a decrease from 2018's peak.
- Serotypes 4, 9V, and 12F showed increasing trends (2018-2022).
- Prevalence of PCV13 serotypes increased (31.2%-41.5%), while non-vaccine types decreased (27.3%-21.5%). Multidrug-resistant IPD rose from 6.7% to 12.6% (2018-2022).
Conclusions:
- IPD cases decreased in 2021 but returned to pre-COVID-19 levels in 2022.
- Increasing prevalence of specific PCV13 and non-PCV13 serotypes (3, 4, 9V, 19F, 12F, 20) observed.
- Continued IPD surveillance is crucial for monitoring serotype distribution and antimicrobial resistance.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Principles of Disease Surveillance
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

